Blood Test Predicts Alzheimer's Disease in Large Cohort
A blood test measuring p-tau217 levels showed strong performance in identifying Alzheimer's disease among participants with an average age of 61. The findings appear in a new issue of a medical journal.
news-medical.netA blood test measuring p-tau217 protein levels identified Alzheimer's disease in a large group of participants whose average age was 61. The results replicate earlier studies and appear on the cover of the latest issue of the journal. Researchers presented the data as further evidence that the test can detect disease-related changes in a younger population than previously studied.
No individual researchers or institutions were named in the report.
Key Facts
Potential Impact
- 01
Earlier detection of Alzheimer's disease may become available for people in their early 60s.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…